Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-β signaling and MicroRNAs

25 Sept 2024

Abstract excerpt

Pulmonary fibrosis (PF) is a highly complex and challenging disease affecting the respiratory system. Patients with PF usually have an abbreviated survival period and a consequential high mortality rate after the diagnosis is confirmed, posing serious threats to human health. In clinical practice, PF is typically treated by antifibrotic agents, such as Pirfenidone and Nintedanib. However, these agents have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Medical Imaging and Pathology Studies
Share to Pulmonary Hypertension Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39386739
DOI: 10.3389/fmed.2024.1415278

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-β signaling and MicroRNAsPMID 39386739Read ↗

Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary FibrosisSemantic proximity Read ↗

MiRNA, a New Treatment Strategy for Pulmonary FibrosisSemantic proximity Read ↗

Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosisSemantic proximity Read ↗

MicroRNAs as potential targets for progressive pulmonary fibrosisSemantic proximity Read ↗

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human BodySemantic proximity Read ↗

MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeuticsSemantic proximity Read ↗

Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal TransitionSemantic proximity Read ↗

MicroRNAs in idiopathic pulmonary fibrosis, new research progress and their pathophysiological implicationSemantic proximity Read ↗

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.Semantic proximity Read ↗

Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.